KORINNE PERRY: Open Payments
NPI 1922525146 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 14 payments from 7 companies in 2025. Trend: 2023 $915 · 2024 $425 · 2025 $446
Food & beverage: $334Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $137 |
| Teva Pharmaceuticals USA, Inc. | 2 | $125 |
| Lundbeck LLC | 3 | $71 |
| Alkermes, Inc. | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: COBENFY, REXULTI, ARISTADA, JOURNAVX, INGREZZA, ABILIFY MAINTENA, UZEDY.
Industry payments across MI — which companies pay providers there.
